Skip to main content
. Author manuscript; available in PMC: 2012 May 24.
Published in final edited form as: Oncogene. 2011 May 23;30(47):4697–4706. doi: 10.1038/onc.2011.179

Table 2.

Expression of CT-RCC HERV-E in fresh (primary) ccRCC tumors and normal kidney tissue obtained from the same nephrectomy samples*.

ID Number ccRCC tumors Normal Kidney n-fold Expression Ratio (tumor/normal kidney)
1012 4.5 3.6 1.2 ± 0.1
1100 11.5 6.3 1.8 ± 0.1
1051 15.2 8.3 1.8 ± 0.1
1040 8.9 4.4 2.0 ± 0.1
1018 16.8 3.8 4.5 ± 0.1
1108 29.5 4.5 6.5 ± 0.3
1027 118.8 4.5 26.5 ± 0.2
1093 1.3 5.3 0.2 ± 0.4
1061 4.9 4.8 1.0 ± 0.3
1096 4.9 3.9 1.3 ± 0.2
1028 9.1 6.1 1.5 ± 0.3
1049 8.2 4.2 1.9 ± 0.3
1005 12.2 4.5 2.7 ± 0.3
1036 13.1 4.0 3.2 ± 0.2
1079 23.7 4.0 5.9 ± 0.2
1129 30.2 4.5 6.7 ± 0.3
1063 459.3 3.8 121.0 ± 0.3
1119 2825.0 4.5 630.4 ± 0.2
1039 2.7 5.9 0.5 ± 0.2
1147 3.6 4.5 0.8 ± 0.2
1111 4.3 4.2 1.0 ± 0.1
1014 3.9 3.0 1.3 ± 0.2
1103 9.5 2.8 3.4 ± 0.2
1077 9.3 2.6 3.5 ± 0.2
1104 18.4 4.5 4.1 ± 0.2
1110 87.8 5.2 16.7 ± 0.2
1068 436.6 3.9 111.0 ± 0.3
median 11.5 4.5 2.7
*

The median copy numbers of the CT-RCC common region relative to RPN1 × 100 and n-fold expression ratio of values for tumors and matched normal kidney tissues are shown.